A Trial to Study BAY1753011 in Patients With Congestive Heart Failure — AVANTI

Heart Failure (HF) Clinical Trial

Official title:
A Multicenter, Randomized, Parallel Group, Double Blind, Active and Placebo Controlled Study of BAY1753011, a Dual V1a/V2 Vasopressin Receptor Antagonist, in Patients With Congestive Heart Failure: AVANTI Study

Status Completed

Clinical Trial Summary

To assess the efficacy of 30 mg of BAY1753011, with or without furosemide, versus furosemide alone in patients with heart failure and objective evidence of congestion.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03901729
Study type	Interventional
Source	Bayer
Contact
Status	Completed
Phase	Phase 2
Start date	May 29, 2019
Completion date	May 21, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03456856` - A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.	Phase 4
Completed	`NCT02301689` - SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register
Completed	`NCT04915118` - A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF
Completed	`NCT02200822` - Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients	Phase 4
Recruiting	`NCT04149743` - HEMOTAG® Assessment for Short-term Outcomes of Heart Failure	N/A
Recruiting	`NCT05652218` - REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)	N/A
Completed	`NCT02127307` - Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.	N/A
Completed	`NCT01936649` - Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.	Phase 4